CDR3 vs CytoReason
CDR3 vs CytoReason, compared side by side on 10 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CDR3 is on 14/100 and CytoReason on 68/100.
Where each one leads
CDR3
Leads on none of the measures we hold for both companies.
CytoReason
- our overall score: 68/100 against 14/100
At a glance
| Measure | CDR3 | CytoReason |
|---|---|---|
| What it is | High-resolution T-cell receptor repertoire analysis for immunological insights and therapeutic development. | Develops a computational model of the human body for drug discovery and development. |
| Category | Healthcare, Immunology, Genomics, Computational Biology | Healthcare, Drug Discovery, Clinical Development, Biomarkers |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2018 | 2016 |
| Headquarters | Not published | Tel Aviv, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | CDR3 | CytoReason |
|---|---|---|
| Employees | Not published | 116 |
| Headcount growthLast 12 months | Not published | +13.7% |
| Total funding | Not published | $128M |
| Latest round | Not published | Series B |
| LinkedIn followers | Not published | 12,830 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CDR3 | CytoReason |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 14/100 | 68/100 |
| Traction | Not published | 60/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 4/100 | 30/100 |
| Quality | Not published | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | Not published | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CDR3 | CytoReason |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CMS | Wix | Not detected |
| Analytics | Not detected | Segment |
CDR3 vs CytoReason: common questions
Which is better, CDR3 or CytoReason?
On our 0-100 score CytoReason rates higher (68/100 against 14/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 10 data points above: read the rows that match what you are buying for.
How do CDR3 and CytoReason compare on the numbers?
CytoReason leads on our overall score (68/100 against 14/100).
Read the full CDR3 review and pricing or the CytoReason review and pricing. You can also browse other CDR3 alternatives we track.